Robot-Only lung surgery may cut costs without sacrificing safety

NCT ID NCT06348030

Not yet recruiting Disease control Sponsor: St. Joseph's Healthcare Hamilton Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two ways of performing robotic lung surgery for early-stage non-small cell lung cancer. In one method, the surgeon controls all tools from a console (totally robotic). In the other, a bedside assistant helps with handheld staplers. The trial will measure costs, operating time, hospital stay, and complications in 120 patients. The goal is to see if the fully robotic approach is more efficient and cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Robotic surgical devices (Vessel Sealer Extend, SureForm stapler, Signia stapler)
What this could lead to: If successful, this could show that totally robotic lung surgery is as safe and less costly than surgeon-assisted methods, potentially becoming the new standard.
What could go wrong: This is a small, early-stage trial (120 people) comparing surgical techniques, not testing a new drug or cure. Results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, L8N 4A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.